![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 11, 7189-7196, March 17, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-1/
-2 Hydroxylase in Mouse Polymorphonuclear Leukocytes





1
From the
Renal Unit and Department of Medicine, Massachusetts General Hospital (East), Charlestown, Massachusetts 02129, the
Department of Pharmacology, University of Colorado Health Sciences Center, Aurora, Colorado 80045, and the ¶Division of Rheumatology and Immunology, and Allergy, Brigham and Women's Hospital, Boston, Massachusetts 02115
Leukotriene B4 (LTB4) is a potent chemoattractant for polymorphonuclear leukocytes (PMN) and other cells. Human PMN inactivate LTB4 by
-oxidation catalyzed by cytochrome P-450 (CYP) 4F3A. The contribution of the enzymatic inactivation of LTB4 by CYP4Fs to down-regulating functional responses of cells to LTB4 is unknown. To elucidate the role of CYP4F-mediated inactivation of LTB4 in terminating the responses of PMN to LTB4 and to identify a target for future genetic studies in mice, we have identified the enzyme that catalyzes the
-1 and
-2 oxidation of LTB4 in mouse myeloid cells as CYP4F18. As determined by mass spectrometry, this enzyme catalyzes the conversion of LTB4 to 19-OH LTB4 and to a lesser extent 18-OH LTB4. Inhibition of CYP4F18 resulted in a marked increase in calcium flux and a 220% increase in the chemotactic response of mouse PMN to LTB4. CYP4F18 expression was induced in bone marrow-derived dendritic cells by bacterial lipopolysaccharide, a ligand for TLR4, and by poly(I·C), a ligand for TLR3. However, when bone marrow-derived myeloid dendritic cells trafficked to popliteal lymph nodes from paw pads, the expression of CYP4F18 was down-regulated. The results identify CYP4F18 as a critical protein in the regulation of LTB4 metabolism and functional responses in mouse PMN and identify it as the functional orthologue of human PMN CYP4F3A.
Received for publication, December 8, 2005
* This work was supported by National Institutes of Health Grants GM-61823 (to R. J. S.), DK59991 (to P. C.), 5R01HL025785-25 (to R. C. M.), 5R01HL068256-03 (to N. C.), R01HL25785 (to R. C. M.), K08 AR 02214-04 and R01 AI 059746-02 (to D. L.), R03DK067940 and the Patricia Weilder Young Investigator Award from the National Kidney Foundation (to B. N.), and a gift from the Jewish Communal Fund (to R. J. S). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Renal Unit and Dept. of Medicine, MA General Hospital (East), Bldg 149, Navy Yard, 13th St., Charlestown, MA 02129. Tel.: 617-726-3747; Fax: 617-726-5669; E-mail: soberman{at}helix.mgh.harvard.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. A. Gijon, S. Zarini, and R. C. Murphy Biosynthesis of eicosanoids and transcellular metabolism of leukotrienes in murine bone marrow cells J. Lipid Res., March 1, 2007; 48(3): 716 - 725. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |